Use of nasal pressure tubes outside the ICU is associated with longer hospital stays and increased costs

Published Date: 06 Mar 2023

In a new study, researchers report the use of inhaled corticosteroids (HFNC) in patients with mild to moderate bronchiolitis...

Read Full News

Latest News

A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.

Response is largely left to the manufacturers after reports of babies who got sick or died

Over 500 Dead in Outbreak; RFK Jr.'s 'Irreparable Harm'; Toddler Alive in the Morgue

Health news and commentary gathered by MedPage Today staff

Mom Who Said Her Toddler Twins Died After Vaccinations Charged With Murder

She is accused of suffocating her 18-month-old children

Flu Shot Offered Robust Protection Against Death in Kids

Vaccination provided ample protection for kids with and without underlying conditions

Younger Teens May Be Unaware of the Dangers of Fentanyl, Survey Says

— Less than half of 8th graders attributed great risk to experimental use

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Fostering Independence

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Fostering Independence

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Response is largely left to the manufacturers after reports of babies who got sick or died

Health news and commentary gathered by MedPage Today staff

She is accused of suffocating her 18-month-old children

Vaccination provided ample protection for kids with and without underlying conditions

— Less than half of 8th graders attributed great risk to experimental use

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Fostering Independence

News All Time

Utah Marks a Year of Battling Measles, With No Clear End in Sight

Outbreaks will likely affect whether the U.S. can keep its measles-free designation

The Knicks Just Gave Us a Teaching Moment. Let's Not Waste It.

This historic win offers valuable lessons for young people's mental health

Shorter TB Regimen Matched Standard Care in Rifampicin-Resistant Disease

Protocol can be used in children and pregnant women

The Truth About 'Looksmaxxing'

Dr. Mike addresses the online epidemic affecting teen boys

New Charter Unveiled for CDC's Influential Vaccine Committee

Changes to rules governing ACIP could inject more politicization, experts warn

'Tiniest Penis' Fundraiser; Flu Vaccine Maker Investigated; FDA Rejects Gout Drug

Health news and commentary gathered by MedPage Today staff

Efforts to End School Vaccine Mandates Hit a Wall in Florida

The outcome could offer insights into such efforts' chances in other states

RFK Jr. Hasn't Restored Trust in Public Health, Cassidy Says

Senate HELP Committee chair also claims "paperwork" is holding up federal health appointments

Vitamin A Linked to Better Lung Function in Kids, Adults With Asthma

Vitamin D levels correlated with lung function only in adults

Pediatricians Should Be Alert for This Deadly Infection in Kids

Brain-eating P. dendritiformis infections could become more common, researcher warns

What Caused This Infant's 'Flaking Paint' Skin Rash?

Disease is common in poverty-stricken areas; cases in U.S. tied to "food fads," restricted diets

US FDA Approves Vertex's Gene Therapy for Sickle Cell Disease in Children as Young as Two

The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' gene therapy in ⁠children as young as two with inherited blood disorders, including...

US FDA Declines Lantheus’ Tumor Imaging Kit Over Third-party Manufacturing Issues

The U.S. Food and Drug Administration declined to approve Lantheus Holdings’ diagnostic ⁠imaging kit for types of cancer tumors, citing unresolved issues at a third-party...

Habit Score Tied to Improved Inhaled Drug Adherence in CF

Habit formation is a key modifiable factor for adherence to inhaled therapy in adults with cystic fibrosis; age, socioeconomic status, neurodivergence and complex regimens also influence adherence.

Ginkgo biloba Adds an Edge in Pediatric Enuresis

Ginkgo biloba extract, alone or in combination with desmopressin, is safe and effective for treating monosymptomatic nocturnal enuresis in children, a trial shows.

Counsel Families on Prevention of Drowning

American Academy of Pediatrics issued a policy statement updating guidance on how to counsel patients and families about preventing drowning.

Recommended News For You

Coffee and tea linked to lower head and neck cancer risk

Study identifies new approach to protect the brain during radiation therapy

Analysis of projected cancer rates in Canada by 2024.

Nuclear missile workers are contracting cancer: They blame the bases

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma

Recommended Articles For You

All You Need to Know About Mesna: The Ultimate Guide 

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology 

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care 

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Taking Charge of Your Cancer Journey.

2.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

3.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

4.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

5.

"We Caught It Early": Advantage or Disadvantage?

1.

How HLH is Revolutionizing Healthcare

2.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

3.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

4.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

5.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

2.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot